These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3754173)

  • 1. The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.
    Birdsall NJ; Hulme EC; Keen M
    Br J Pharmacol; 1986 Feb; 87(2):307-16. PubMed ID: 3754173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX; Mei L; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA; Williams GW; DeSantis LM
    Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    Poyner DR; Birdsall NJ; Curtis C; Eveleigh P; Hulme EC; Pedder EK; Wheatley M
    Mol Pharmacol; 1989 Sep; 36(3):420-9. PubMed ID: 2506431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M; Waelbroeck M; Christophe J
    J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]oxotremorine-M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors.
    Bevan P
    Eur J Pharmacol; 1984 May; 101(1-2):101-10. PubMed ID: 6547676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization and characterization of atrial muscarinic acetylcholine receptors in sucrose monolaurate.
    Rinken A; Haga T
    Arch Biochem Biophys; 1993 Feb; 301(1):158-64. PubMed ID: 8442658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment, solubilization, and partial characterization of digitonin-solubilized muscarinic receptors derived from canine ventricular myocardium.
    Manalan AS; Werth DK; Jones LR; Watanabe AM
    Circ Res; 1983 Jun; 52(6):664-76. PubMed ID: 6305530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL; el-Fakahany EE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.
    Hammer R; Giraldo E; Schiavi GB; Monferini E; Ladinsky H
    Life Sci; 1986 May; 38(18):1653-62. PubMed ID: 3754610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
    Wreggett KA; Wells JW
    J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.